Heparin-induced thrombocytopenia in cancer.
Journal Article (Journal Article;Review)
Heparin-induced thrombocytopenia is a common and clinically important drug-induced complication that can cause life- and limbthreatening thrombosis. Epidemiologically, the disease has been studied in many different clinical settings, but little is known about it in cancer patients, a population at increased risk for thrombosis and thus exposure to heparin products. Additionally, thrombocytopenia is a common finding in cancer patients. The convergence of these variables highlights the importance of an increased understanding of the disease in cancer patients.
- Miriovsky, BJ; Ortel, TL
- July 1, 2011
Volume / Issue
- 9 / 7
Start / End Page
- 781 - 787
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
- United States